Analystreport

10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

10x Genomics, Inc.  (TXG) 
Last 10x genomics, inc. earnings: 2/18 04:01 pm Check Earnings Report